The second section consists of eight chapters, where approaches to production of proteins, crystallization of membrane proteins, and study of protein structures by means of X-ray analysis and NMR-spectroscopy are discussed. Some chapters describe methods of modification of protein structures, including secondary structure.
The third section containing six chapters considers methods of identification of possible errors during design of models of protein tertiary structure. This section also includes a description of the principles of evolutionary classification of protein structures and use of data on protein structure for drug design based on structure of biologically active proteins such as serine proteases, kinases, phosphatases, and their inhibitors. A special chapter in this section introduces the European Bioinformatics Institute (UK, web-site http://www.ebi.ac.uk) founded in 1995. This institute has huge database of protein structures.
The fourth section deals with some problems related to use of structural data for drug design. Particularly, it considers dependence of interferon activity on its structure and mechanisms of action of G-protein coupled receptor family and their structural relationship with rhodopsin.
This book will be useful for biochemists, specialists in bioorganic chemistry, protein structure, and also for biotechnologists and pharmacologists involved in protein structure based drug design.
Doctor of Biological Sciences
G. Ya. Wiederschain